Brisbane Transplant Infectious Diseases meeting 2024

1 Jul 2024

The Centre for Research Excellence in Personalising antimicrobial dosing to reduce resistance (CRE RESPOND) recently held a highly successful interdisciplinary and collaborative meeting on transplant and infectious diseases care.

The 2nd Brisbane Transplant Infectious Diseases Meeting, held at the Translational Research Institute on the Princess Alexandra Hospital campus, brought together local and interstate clinicians, scientists, donor coordinators, pharmacists and other healthcare professionals working in the field of infectious diseases, immunology, and transplant medicine.

Experts from diverse disciplines including infectious diseases, transplant medicine, immunology, microbiology, pharmacy and transplant donor coordination shared clinical insights and the latest advancements in their respective fields. This unique gathering provided a platform for researchers and clinicians to exchange ideas and build relationships across different specialties, which will pave the way for future interdisciplinary research and clinical collaborations.

The workshop was privileged to host distinguished experts from Queensland and interstate including:

  1. Dr Liv Smibert, Austin Health, Peter MacCallum Cancer Centre and University of Melbourne: having completed a fellowship at Transplant Infectious Diseases fellowship at the Massachusetts General Hospital, Harvard University, Dr Smibert is a leading transplant infectious diseases expert and awarded researcher currently investigating the role of microbiome in determining infectious and immunological outcomes in immune compromised patients and the role this could play in development of novel therapeutics and diagnostics.
  2. Dr Bradley Gardiner, Alfred Health, Monash University: Dr Gardiner is an Infectious Diseases Physician and researcher. Having completed his PhD focusing on individualisation of CMV prevention and management strategies in transplant recipients, he is an active contributor to international guidelines on the management of CMV in transplant recipients.
  3. Associate Profession Benjamin Teh, Peter MacCallum Cancer Centre, National Centre for Infections in Cancer: Dr Teh is an Infectious Diseases physician and clinical researcher. His research interests encompass translational immune profiling, clinical studies of infection risks with new cancer therapies and vaccination in cancer patients. 
  4. Dr Tina Marinelli, Royal Prince Alfred Hospital: Dr Tina Marinelli is an Infectious Diseases staff specialist with subspeciality interest in infections in the immunocompromised host and transplant recipients.
  5.  Professor Rajiv Khanna (QIMR Berghofer Medical Research Institute): Dr Khanna, a world leader in the field of T-cell immunotherapeutic strategies, holds a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia and is a Fellow of the Australian Academy of Health and Medical Sciences. In 2017, he was appointed officer of the Order of Australia for distinguished services to medicine in the field of immunology.

Key highlights of the full-day seminar included:

  • Interdisciplinary engagement: This meeting brought together clinicians, scientists and other healthcare professionals from diverse disciplines focusing on transplant and infectious diseases care.
  • Exploring cutting-edge research: Presentations showcased cutting-edge research in areas such as metagenomics, molecular microbiology and cellular therapies for infectious diseases.
  • Addressing clinical challenges: Sessions and case presentations focused on practical challenges faced in clinical practice, providing a platform for researchers and clinicians to exchange ideas and share insights, as well as identifying crucial areas for future research and clinical collaborations.

This full-day seminar marks the fifth event in CRE RESPOND's 2024 education program. As an organization committed to advancing clinical practice and scientific understanding, CRE RESPOND remains dedicated to providing essential, clinically focused events for clinicians, scientists, and policy-makers. 

For more information about CRE RESPOND and upcoming events, please visit CRE RESPOND